Picture of Heidelberg Pharma AG logo

HPHA Heidelberg Pharma AG Balance Sheet

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Heidelberg Pharma AG, fiscal year end - November 30th, EUR millions except per share, conversion factor applied.

2021
November 30th
2022
November 30th
2023
November 30th
2024
November 30th
2025
November 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments6.1481.343.429.415
Net Total Accounts Receivable
Net Total Receivables1.451.452.325.952.35
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets9.0187.956.647.628.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3.673.723.853.490.912
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets21.710170.460.738.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities14.927.919.8811.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1533.92129.949.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity6.766.649.330.9-10.9
Total Liabilities & Shareholders' Equity21.710170.460.738.1
Total Common Shares Outstanding